Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions: Multicenter analysis.

Atsushi HiraokaTakashi KumadaKazuya KariyamaKoichi TakaguchiMasanori AtsukawaEi ItobayashiKunihiko TsujiKazuto TajiriMasashi HirookaNoritomo ShimadaHiroshi ShibataToru IshikawaHironori OchiToshifumi TadaHidenori ToyodaKazuhiro NousoAkemi TsutsuiNorio ItokawaMichitaka ImaiKouji JokoYoichi HiasaKojiro Michitakanull null

Published in: Cancer medicine (2018)

Regardless of past TKI therapy, therapeutic response and AEs after introducing LEN were similar. LEN may be an important treatment for the present unmet need regarding TKI treatment against u-HCC.

Keyphrases

tyrosine kinase
advanced non small cell lung cancer
squamous cell carcinoma
stem cells
clinical trial
combination therapy
locally advanced
epidermal growth factor receptor
liver metastases
data analysis